Jonathan Downar, MD, PhD
- 4Articles
- 38.7KReads1
- 2018–2022Active
- 47Collaborators
- 188Citations2
About
Jonathan Downar, MD, PhD, is affiliated with the Department of Psychiatry at the University of Toronto. His publications from 2018 to 2022 focus on major depressive disorder and suicide, including studies on repetitive transcranial magnetic stimulation, magnetic seizure therapy, and pharmacological treatments such as escitalopram and aripiprazole. He has collaborated frequently with researchers including Benoit H. Mulsant, Daniel M. Blumberger, and Zafiris J. Daskalakis.
Publications
Effect of rTMS on Suicidal Ideation in Treatment-Resistant Depression
January 18, 2022
Continuation MST for Treatment-Resistant Depression
October 19, 2021
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
